Ryan Potts
Executive Director and Head of Induced Proximity Platform
Amgen
Ryan Potts, Ph.D. obtained his B.S. in Biology from the University of North Carolina and his Ph.D. in Cell and Molecular Biology from UT Southwestern in 2007. In 2008 he was awarded the Sara and Frank McKnight junior faculty position at UT Southwestern Medical Center. During this time his lab focused on answering a long-standing question in cancer biology regarding the cellular function of cancer-testis antigen (CTAs) proteins. In 2011 he was appointed Assistant Professor in the Departments of Physiology, Pharmacology, and Biochemistry at UT Southwestern Medical Center. His lab’s work defined a function for the enigmatic MAGE gene family in protein regulation through ubiquitination. In 2016 his lab moved to St. Jude Children’s Research Hospital where he was an Associate Member in the Department of Cell and Molecular Biology. There his lab continued to work on CTAs, with a focus on elucidating the biochemical, cellular, physiological and pathological functions of the MAGE gene family. In 2020 he moved to Amgen, Inc. in Thousand Oaks, California to build a new department called the Induced Proximity Platform (IPP) that is focused on drugging the “undruggable”.
Kristine McKinney
Associate Director - Target Biology and Translational Medicine
Arrakis
Yochi Slonim
Co-Founder and CEO
Anima Biotech
Marie-Eve Beaulieu
CSO & Co-Founder
Peptomyc
Judith Frydman
Professor
Stanford University
Johanne Caplan
CDO
ProMIS Neurosciences
Alexander Scheer
CSO
Aelin Therapeutics
